Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Catheter Ablation of Advanced Forms of Atrial Fibrillation

NCT: NCT07446244 · ENROLLING_BY_INVITATION

NCT IDNCT07446244
StatusENROLLING_BY_INVITATION
Start Date2026-03-25
Completion2028-03-01

Brief Summary

The purpose of this study is to evaluate feasibility, safety, and efficacy of pulmonary vein isolation combined with posterior left atrial isolation and multiple linear lesions in both atria in patients with persistent and long-standing persistent atrial fibrillation.

Frequently Asked Questions

What is Catheter Ablation of Advanced Forms of Atrial Fibrillation?

Catheter Ablation of Advanced Forms of Atrial Fibrillation is a clinical trial registered under NCT07446244. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07446244?

The current status of NCT07446244 (Catheter Ablation of Advanced Forms of Atrial Fibrillation) is: ENROLLING_BY_INVITATION.

When did Catheter Ablation of Advanced Forms of Atrial Fibrillation start?

Catheter Ablation of Advanced Forms of Atrial Fibrillation started on 2026-03-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.